The global acetazolamide market is anticipated to grow at a significant CAGR during the forecast period (2022-2028). Acetazolamide is a carbonic anhydrase inhibitor used to treat chronic simple (open-angle) glaucoma, secondary glaucoma, acute angle-closure glaucoma, epilepsy, edoema from congestive heart failure, drug-induced edoema, and acute mountain sickness in climbers. Acetazolamide aids altitude adaptation by increasing renal bicarbonate production, inducing metabolic acidosis, and stimulating breathing. Thus, the rising demand and requirement for acetazolamide drug to treat such health concerns is expected to bolster the market’s growth globally.
(Get 15% Discount on Buying this Report)
A full report is available at : https://orionmarketreports.com/global-acetazolamide/92782/
Increasing prevalence of glaucoma and associated risk factors such as high myopia, diabetes, eye surgery or injury, high blood pressure, and increased use of corticosteroids are expected to provide favorable growth opportunities for the acetazolamide drug manufacturers. According to the Centers for Disease Control and Prevention (CDC), in November 2022, around 3 million people in the US were diagnosed with glaucoma. Glaucoma is also considered to be the cause of blindness. Acetazolamide drugs lowers ocular pressure prevents damage to the eyes. In addition, it also reduces ocular pressure by inhibiting the function of an enzyme known as carbonic anhydrase, which deacreases the quantity of fluid secreted in the the eye.
Market Coverage
The market number available for – 2022-2028
Base year- 2021
Forecast period- 2022-2028
Segment Covered-
By Type
By Application
By Distribution Channel
Regions Covered-
- North America
- Europe
- Asia-Pacific
Rest of the World
Competitive Landscape– Teva Pharmaceutical Industries Ltd., Accord Healthcare, Avet Pharmaceuticals Inc., Nostrum Laboratories Inc., Zydus Pharmaceuticals, Inc. among others.
Key questions addressed by the report
- What is the market growth rate?
- Which segment and region dominate the market in the base year?
- Which segment and region will project the fastest growth in the market?
- How has COVID-19 impacted the market?
- Deviation from the pre-COVID-19 forecast
- Most affected region and segment
- Who is the leader in the market?
- How are playersaddressing challenges to sustain growth?
- Where is the investment opportunity?
Global Acetazolamide Market Report by Segment
By Type
- Tablet
- Capsule
- Injection
By Application
- Glaucoma
- Epilepsy
- Drug-induced Edema
- Altitude Sickness
- Fluid Retention
- Heart Failure
- Seizures
By Distribution Channel
- Hospitals
- Drug Stores
- Others
About Us:
Orion Market Reports (OMR) endeavors to provide exclusive blend of qualitative and quantitative market research reports to clients across the globe. Our organization helps both multinational and domestic enterprises to bolster their business by providing in-depth market insights and most reliable future market trends. Our reports address all the major aspects of the markets providing insights and market outlook to global clients.
Media Contact:
Company Name : Orion Market Reports
Contact Person : Mr. Anurag Tiwari
Email : Info@orionmarketreports.com
Contact No : +91 780-304-0404
This release has been published on Global market Post
Global market Post is not responsible for any content included in this release.
